Page last updated: 2024-08-24

loxiglumide and Gastric Diseases

loxiglumide has been researched along with Gastric Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brzozowski, T; Drozdowicz, D; Hahn, EG; Konturek, PC; Konturek, SJ; Kwiecien, S; Moran, AP; Pajdo, R; Pawlik, WW; Sliwowski, Z1
Abergel, A; Bommelaer, G; Boulant, J; D'Amato, M; Dapoigny, M; Mathieu, S1

Trials

1 trial(s) available for loxiglumide and Gastric Diseases

ArticleYear
Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.
    Gut, 1997, Volume: 40, Issue:5

    Topics: Adult; Cholecystokinin; Double-Blind Method; Esophagogastric Junction; Female; Gastroesophageal Reflux; Hormone Antagonists; Humans; Male; Manometry; Pressure; Proglumide; Receptors, Cholecystokinin; Stomach Diseases

1997

Other Studies

1 other study(ies) available for loxiglumide and Gastric Diseases

ArticleYear
Involvement of capsaicin-sensitive afferent nerves and cholecystokinin 2/gastrin receptors in gastroprotection and adaptation of gastric mucosa to Helicobacter pylori-lipopolysaccharide.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:1

    Topics: Adaptation, Biological; Animals; Aspirin; Blotting, Western; Capsaicin; Gastric Acid; Gastric Mucosa; Gastrins; Helicobacter pylori; Hormone Antagonists; Interleukin-1; Leptin; Lipopolysaccharides; Male; Neurons, Afferent; Proglumide; Protective Agents; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Diseases; Tumor Necrosis Factor-alpha

2004